Not sure why the UCLE selloff. I actually snagged some at .11-.13. Looks cheap. Solid Q2 results. Tough comp, so numbers down vs. last year. But a big sequential improvement. And the Q2 earnings PR said they had a substantial backlog (or back-log ha) that would ship in Q3 & Q4. So hopefully the sequential improvements continue. If Q3 earnings come in at .01+/share, stock is a steal here. Company is trying to do a small offering...and they seem to think people will pay .30/share. Maybe they will if Q3 is strong. Also some interesting news from earlier this month:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.